1
|
Mills LR, Di Mare F, Gygi D, Lee H, Simmons EM, Kim J, Wisniewski SR, Chirik PJ. Phenoxythiazoline (FTz)-Cobalt(II) Precatalysts Enable C(sp 2 )-C(sp 3 ) Bond-Formation for Key Intermediates in the Synthesis of Toll-like Receptor 7/8 Antagonists. Angew Chem Int Ed Engl 2023:e202313848. [PMID: 37917119 DOI: 10.1002/anie.202313848] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 11/01/2023] [Accepted: 11/02/2023] [Indexed: 11/03/2023]
Abstract
Evaluation of the relative rates of the cobalt-catalyzed C(sp2 )-C(sp3 ) Suzuki-Miyaura cross-coupling between the neopentylglycol ester of 4-fluorophenylboronic acid and N-Boc-4-bromopiperidine established that smaller N-alkyl substituents on the phenoxyimine (FI) supporting ligand accelerated the overall rate of the reaction. This trend inspired the design of optimal cobalt catalysts with phenoxyoxazoline (FOx) and phenoxythiazoline (FTz) ligands. An air-stable cobalt(II) precatalyst, (FTz)CoBr(py)3 was synthesized and applied to the cross-coupling of an indole-5-boronic ester nucleophile with a piperidine-4-bromide electrophile that is relevant to the synthesis of reported toll-like receptor (TLR) 7/8 antagonist molecules including afimetoran. Addition of excess KOMe⋅B(Oi Pr)3 improved catalyst lifetime due to attenuation of alkoxide basicity that otherwise resulted in demetallation of the FI chelate. A first-order dependence on the cobalt precatalyst and a saturation regime in nucleophile were observed, supporting turnover-limiting transmetalation and the origin of the observed trends in N-imine substitution.
Collapse
Affiliation(s)
- L Reginald Mills
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| | - Francesca Di Mare
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| | - David Gygi
- Chemical Process Development, Bristol Myers Squibb Company, New Brunswick, NJ 08903, USA
| | - Heejun Lee
- Chemical Process Development, Bristol Myers Squibb Company, New Brunswick, NJ 08903, USA
| | - Eric M Simmons
- Chemical Process Development, Bristol Myers Squibb Company, New Brunswick, NJ 08903, USA
| | - Junho Kim
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| | - Steven R Wisniewski
- Chemical Process Development, Bristol Myers Squibb Company, New Brunswick, NJ 08903, USA
| | - Paul J Chirik
- Department of Chemistry, Princeton University, Princeton, NJ 08544, USA
| |
Collapse
|
2
|
Kazmi MZH, Schneider OM, Hall DG. Expanding the Role of Boron in New Drug Chemotypes: Properties, Chemistry, Pharmaceutical Potential of Hemiboronic Naphthoids. J Med Chem 2023; 66:13768-13787. [PMID: 37752013 DOI: 10.1021/acs.jmedchem.3c01194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 09/28/2023]
Abstract
New chemotypes and bioisosteres can open a new chemical space in drug discovery and help meet an urgent demand for novel agents to fight infections and other diseases. With the aim of identifying new boron-containing drug chemotypes, this article details a comprehensive evaluation of the pseudoaromatic hemiboronic naphthoids, benzoxaza- and benzodiazaborines. Relevant physical properties in aqueous media (acidity, solubility, log P, and stability) of prototypic members of four subclasses were determined. Both scaffolds are amenable to common reactions used in drug discovery, such as chemoselective Suzuki-Miyaura, Chan-Lam, and amidation reactions. Small model libraries were prepared to assess the scope of these transformations, and the entire collection was screened for antifungal (Candida albicans) and antibacterial activity (MRSA, Escherichia coli), unveiling promising benzoxazaborines with low micromolar minimum inhibitory concentration values. Select DMPK assays of representative compounds suggest promising drug-like behavior for all four subclasses. Moreover, several drug isosteres were evaluated for anti-inflammatory and anticancer activity as appropriate.
Collapse
Affiliation(s)
- M Zain H Kazmi
- Department of Chemistry, Centennial Center for Interdisciplinary Science, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
| | - Olivia M Schneider
- Department of Chemistry, Centennial Center for Interdisciplinary Science, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
| | - Dennis G Hall
- Department of Chemistry, Centennial Center for Interdisciplinary Science, University of Alberta, Edmonton, Alberta T6G 2G2, Canada
| |
Collapse
|
3
|
Tevyashova AN, Chudinov MV. Progress in the medicinal chemistry of organoboron compounds. RUSSIAN CHEMICAL REVIEWS 2021; 90:451-487. [DOI: 10.1070/rcr4977] [Citation(s) in RCA: 18] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2025]
Abstract
The review aims to draw attention to the latest advances in the organoboron chemistry and therapeutic use of organoboron compounds. The synthetic strategies towards boron-containing compounds with proven in vitro and/or in vivo biological activities, including derivatives of boronic acids, benzoxaboroles, benzoxaborines and benzodiazaborines, are summarized. Approaches to the synthesis of hybrid structures containing an organoboron moiety as one of the pharmacophores are considered, and the effect of this modification on the pharmacological activity of the initial molecules is analyzed. On the basis of analysis of the published data, the most promising areas of research in the field of organoboron compounds are identified, including the latest methods of synthesis, modification and design of effective therapeutic agents.
The bibliography includes 246 references.
Collapse
|
4
|
Neochoritis CG, Zarganes-Tzitzikas T, Novotná M, Mitríková T, Wang Z, Kurpiewska K, Kalinowska-Tłuścik J, Dömling A. Isocyanide-Based Multicomponent Reactions of Free Phenylboronic Acids. EUROPEAN JOURNAL OF CHEMISTRY (PRINT) 2019; 2019:6132-6137. [PMID: 33981465 PMCID: PMC8112803 DOI: 10.1002/ejoc.201901187] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/09/2019] [Indexed: 12/14/2022]
Abstract
Boronic acids are amongst the most useful synthetic intermediates, frequently used by modern drug design. However, their access and fast synthesis of libraries are often problematic. We present a methodology on the synthesis of drug-like scaffolds via IMCRs with unprotected phenylboronic acids. To demonstrate an application of our approach, we also performed one-pot Suzuki couplings on the primary MCR scaffolds. Moreover, we performed a thorough data-mining of the Cambridge Structural Database, revealing interesting geometrical features.
Collapse
Affiliation(s)
- Constantinos G Neochoritis
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
- Department of Chemistry, University of Crete, Panepistimioupoli Vouton, T.K 70013 Iraklio, Crete, Greece
| | - Tryfon Zarganes-Tzitzikas
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
| | - Michaela Novotná
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
| | - Tatiana Mitríková
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
| | - Zefeng Wang
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
| | - Katarzyna Kurpiewska
- Faculty of Chemistry, Jagiellonian University, Gronostajowa 2, 30-387 Krakow, Poland
| | | | - Alexander Dömling
- Department of Pharmacy, Drug Design Group, University of Groningen, A. Deusinglaan 1, 9713 AV, The Netherlands
| |
Collapse
|
5
|
Neochoritis CG, Shaabani S, Ahmadianmoghaddam M, Zarganes-Tzitzikas T, Gao L, Novotná M, Mitríková T, Romero AR, Irianti MI, Xu R, Olechno J, Ellson R, Helan V, Kossenjans M, Groves MR, Dömling A. Rapid approach to complex boronic acids. SCIENCE ADVANCES 2019; 5:eaaw4607. [PMID: 31281893 PMCID: PMC6611686 DOI: 10.1126/sciadv.aaw4607] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/21/2018] [Accepted: 05/30/2019] [Indexed: 05/28/2023]
Abstract
The compatibility of free boronic acid building blocks in multicomponent reactions to readily create large libraries of diverse and complex small molecules was investigated. Traditionally, boronic acid synthesis is sequential, synthetically demanding, and time-consuming, which leads to high target synthesis times and low coverage of the boronic acid chemical space. We have performed the synthesis of large libraries of boronic acid derivatives based on multiple chemistries and building blocks using acoustic dispensing technology. The synthesis was performed on a nanomole scale with high synthesis success rates. The discovery of a protease inhibitor underscores the usefulness of the approach. Our acoustic dispensing-enabled chemistry paves the way to highly accelerated synthesis and miniaturized reaction scouting, allowing access to unprecedented boronic acid libraries.
Collapse
Affiliation(s)
- Constantinos G. Neochoritis
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Shabnam Shaabani
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Maryam Ahmadianmoghaddam
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Tryfon Zarganes-Tzitzikas
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Li Gao
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Michaela Novotná
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Tatiana Mitríková
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Atilio Reyes Romero
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Marina Ika Irianti
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Ruixue Xu
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Joe Olechno
- Labcyte Inc., 170 Rose Orchard Way, San Jose, CA 95134, USA
| | - Richard Ellson
- Labcyte Inc., 170 Rose Orchard Way, San Jose, CA 95134, USA
| | - Victoria Helan
- Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Gothenburg SE-43183, Sweden
| | - Michael Kossenjans
- Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Mölndal, Gothenburg SE-43183, Sweden
| | - Matthew R. Groves
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| | - Alexander Dömling
- Pharmacy Department, Drug Design group, University of Groningen, Deusinglaan 1, 9700 AV Groningen, Netherlands
| |
Collapse
|
6
|
Fuscaldo RS, Vontobel PHV, Boeira EO, Moro AV, Costa JSD. Synthesis of Amino- and Hydroxymethyl Benzoxaboroles: Prominent Scaffolds for Further Functionalization. European J Org Chem 2019. [DOI: 10.1002/ejoc.201900013] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Affiliation(s)
- Rodrigo S. Fuscaldo
- Instituto de Química; Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, 91501-970, Porto Alegre, RS; Brazil
| | - Pedro H. V. Vontobel
- Instituto de Química; Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, 91501-970, Porto Alegre, RS; Brazil
| | - Eduam O. Boeira
- Instituto de Química; Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, 91501-970, Porto Alegre, RS; Brazil
| | - Angélica V. Moro
- Instituto de Química; Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, 91501-970, Porto Alegre, RS; Brazil
| | - Jessie S. da Costa
- Instituto de Química; Universidade Federal do Rio Grande do Sul, Av. Bento Gonçalves 9500, 91501-970, Porto Alegre, RS; Brazil
| |
Collapse
|